List of Tables
Table 1. Global Medications for Canine Atopic Dermatitis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Medications for Canine Atopic Dermatitis Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Medications for Canine Atopic Dermatitis Market Competitive Situation by Manufacturers in 2024
Table 4. Global Medications for Canine Atopic Dermatitis Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Medications for Canine Atopic Dermatitis Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Medications for Canine Atopic Dermatitis Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Medications for Canine Atopic Dermatitis Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Medications for Canine Atopic Dermatitis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Medications for Canine Atopic Dermatitis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Product Type & Application
Table 12. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medications for Canine Atopic Dermatitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Canine Atopic Dermatitis as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medications for Canine Atopic Dermatitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Medications for Canine Atopic Dermatitis Sales by Region (2020-2025) & (K Units)
Table 18. Global Medications for Canine Atopic Dermatitis Sales Market Share by Region (2020-2025)
Table 19. Global Medications for Canine Atopic Dermatitis Sales by Region (2026-2031) & (K Units)
Table 20. Global Medications for Canine Atopic Dermatitis Sales Market Share by Region (2026-2031)
Table 21. Global Medications for Canine Atopic Dermatitis Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Region (2020-2025)
Table 23. Global Medications for Canine Atopic Dermatitis Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Region (2026-2031)
Table 25. North America Medications for Canine Atopic Dermatitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Medications for Canine Atopic Dermatitis Sales by Country (2020-2025) & (K Units)
Table 27. North America Medications for Canine Atopic Dermatitis Sales by Country (2026-2031) & (K Units)
Table 28. North America Medications for Canine Atopic Dermatitis Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Medications for Canine Atopic Dermatitis Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Medications for Canine Atopic Dermatitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Medications for Canine Atopic Dermatitis Sales by Country (2020-2025) & (K Units)
Table 32. Europe Medications for Canine Atopic Dermatitis Sales by Country (2026-2031) & (K Units)
Table 33. Europe Medications for Canine Atopic Dermatitis Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Medications for Canine Atopic Dermatitis Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Medications for Canine Atopic Dermatitis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Medications for Canine Atopic Dermatitis Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Medications for Canine Atopic Dermatitis Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Medications for Canine Atopic Dermatitis Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Medications for Canine Atopic Dermatitis Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Medications for Canine Atopic Dermatitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Medications for Canine Atopic Dermatitis Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Medications for Canine Atopic Dermatitis Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Medications for Canine Atopic Dermatitis Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Medications for Canine Atopic Dermatitis Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Medications for Canine Atopic Dermatitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Medications for Canine Atopic Dermatitis Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Medications for Canine Atopic Dermatitis Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Medications for Canine Atopic Dermatitis Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Medications for Canine Atopic Dermatitis Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Medications for Canine Atopic Dermatitis Sales (K Units) by Type (2020-2025)
Table 51. Global Medications for Canine Atopic Dermatitis Sales (K Units) by Type (2026-2031)
Table 52. Global Medications for Canine Atopic Dermatitis Sales Market Share by Type (2020-2025)
Table 53. Global Medications for Canine Atopic Dermatitis Sales Market Share by Type (2026-2031)
Table 54. Global Medications for Canine Atopic Dermatitis Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Medications for Canine Atopic Dermatitis Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Type (2020-2025)
Table 57. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Type (2026-2031)
Table 58. Global Medications for Canine Atopic Dermatitis Price (US$/Unit) by Type (2020-2025)
Table 59. Global Medications for Canine Atopic Dermatitis Price (US$/Unit) by Type (2026-2031)
Table 60. Global Medications for Canine Atopic Dermatitis Sales (K Units) by Application (2020-2025)
Table 61. Global Medications for Canine Atopic Dermatitis Sales (K Units) by Application (2026-2031)
Table 62. Global Medications for Canine Atopic Dermatitis Sales Market Share by Application (2020-2025)
Table 63. Global Medications for Canine Atopic Dermatitis Sales Market Share by Application (2026-2031)
Table 64. Global Medications for Canine Atopic Dermatitis Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Medications for Canine Atopic Dermatitis Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Application (2020-2025)
Table 67. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Application (2026-2031)
Table 68. Global Medications for Canine Atopic Dermatitis Price (US$/Unit) by Application (2020-2025)
Table 69. Global Medications for Canine Atopic Dermatitis Price (US$/Unit) by Application (2026-2031)
Table 70. GlenHaven Company Information
Table 71. GlenHaven Description and Business Overview
Table 72. GlenHaven Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GlenHaven Medications for Canine Atopic Dermatitis Product
Table 74. GlenHaven Recent Developments/Updates
Table 75. DermaPet Company Information
Table 76. DermaPet Description and Business Overview
Table 77. DermaPet Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. DermaPet Medications for Canine Atopic Dermatitis Product
Table 79. DermaPet Recent Developments/Updates
Table 80. DVM Pharmaceuticals Company Information
Table 81. DVM Pharmaceuticals Description and Business Overview
Table 82. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product
Table 84. DVM Pharmaceuticals Recent Developments/Updates
Table 85. Virbac Company Information
Table 86. Virbac Description and Business Overview
Table 87. Virbac Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Virbac Medications for Canine Atopic Dermatitis Product
Table 89. Virbac Recent Developments/Updates
Table 90. Enzo Life Sciences, Inc. Company Information
Table 91. Enzo Life Sciences, Inc. Description and Business Overview
Table 92. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product
Table 94. Enzo Life Sciences, Inc. Recent Developments/Updates
Table 95. Pfizer Animal Health Company Information
Table 96. Pfizer Animal Health Description and Business Overview
Table 97. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Animal Health Medications for Canine Atopic Dermatitis Product
Table 99. Pfizer Animal Health Recent Developments/Updates
Table 100. Novartis Animal Health, Inc. Company Information
Table 101. Novartis Animal Health, Inc. Description and Business Overview
Table 102. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product
Table 104. Novartis Animal Health, Inc. Recent Developments/Updates
Table 105. Eli Lilly and Company Company Information
Table 106. Eli Lilly and Company Description and Business Overview
Table 107. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Eli Lilly and Company Medications for Canine Atopic Dermatitis Product
Table 109. Eli Lilly and Company Recent Developments/Updates
Table 110. Perrigo Company Information
Table 111. Perrigo Description and Business Overview
Table 112. Perrigo Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Perrigo Medications for Canine Atopic Dermatitis Product
Table 114. Perrigo Recent Developments/Updates
Table 115. Merck & Company Company Information
Table 116. Merck & Company Description and Business Overview
Table 117. Merck & Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Merck & Company Medications for Canine Atopic Dermatitis Product
Table 119. Merck & Company Recent Developments/Updates
Table 120. Zoetis Inc. Company Information
Table 121. Zoetis Inc. Description and Business Overview
Table 122. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Zoetis Inc. Medications for Canine Atopic Dermatitis Product
Table 124. Zoetis Inc. Recent Developments/Updates
Table 125. Toray Industries, Inc Company Information
Table 126. Toray Industries, Inc Description and Business Overview
Table 127. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Toray Industries, Inc Medications for Canine Atopic Dermatitis Product
Table 129. Toray Industries, Inc Recent Developments/Updates
Table 130. Bayer Animal Health Company Information
Table 131. Bayer Animal Health Description and Business Overview
Table 132. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Bayer Animal Health Medications for Canine Atopic Dermatitis Product
Table 134. Bayer Animal Health Recent Developments/Updates
Table 135. Putney, Inc. Company Information
Table 136. Putney, Inc. Description and Business Overview
Table 137. Putney, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Putney, Inc. Medications for Canine Atopic Dermatitis Product
Table 139. Putney, Inc. Recent Developments/Updates
Table 140. Dechra Company Information
Table 141. Dechra Description and Business Overview
Table 142. Dechra Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Dechra Medications for Canine Atopic Dermatitis Product
Table 144. Dechra Recent Developments/Updates
Table 145. Elanco Company Information
Table 146. Elanco Description and Business Overview
Table 147. Elanco Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Elanco Medications for Canine Atopic Dermatitis Product
Table 149. Elanco Recent Developments/Updates
Table 150. Kindred Biosciences Company Information
Table 151. Kindred Biosciences Description and Business Overview
Table 152. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Kindred Biosciences Medications for Canine Atopic Dermatitis Product
Table 154. Kindred Biosciences Recent Developments/Updates
Table 155. Nippon Zenyaku Kogyo Co., Ltd. Company Information
Table 156. Nippon Zenyaku Kogyo Co., Ltd. Description and Business Overview
Table 157. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product
Table 159. Nippon Zenyaku Kogyo Co., Ltd. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Medications for Canine Atopic Dermatitis Distributors List
Table 163. Medications for Canine Atopic Dermatitis Customers List
Table 164. Medications for Canine Atopic Dermatitis Market Trends
Table 165. Medications for Canine Atopic Dermatitis Market Drivers
Table 166. Medications for Canine Atopic Dermatitis Market Challenges
Table 167. Medications for Canine Atopic Dermatitis Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medications for Canine Atopic Dermatitis
Figure 2. Global Medications for Canine Atopic Dermatitis Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Medications for Canine Atopic Dermatitis Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. External Use Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Medications for Canine Atopic Dermatitis Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Medications for Canine Atopic Dermatitis Market Share by Application: 2024 & 2031
Figure 9. Veterinary Hospital
Figure 10. Veterinary Clinic
Figure 11. Global Medications for Canine Atopic Dermatitis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Medications for Canine Atopic Dermatitis Market Size (2020-2031) & (US$ Million)
Figure 13. Global Medications for Canine Atopic Dermatitis Sales (2020-2031) & (K Units)
Figure 14. Global Medications for Canine Atopic Dermatitis Average Price (US$/Unit) & (2020-2031)
Figure 15. Medications for Canine Atopic Dermatitis Report Years Considered
Figure 16. Medications for Canine Atopic Dermatitis Sales Share by Manufacturers in 2024
Figure 17. Global Medications for Canine Atopic Dermatitis Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Medications for Canine Atopic Dermatitis Players: Market Share by Revenue in Medications for Canine Atopic Dermatitis in 2024
Figure 19. Medications for Canine Atopic Dermatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Medications for Canine Atopic Dermatitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Medications for Canine Atopic Dermatitis Sales Market Share by Country (2020-2031)
Figure 22. North America Medications for Canine Atopic Dermatitis Revenue Market Share by Country (2020-2031)
Figure 23. United States Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Medications for Canine Atopic Dermatitis Sales Market Share by Country (2020-2031)
Figure 26. Europe Medications for Canine Atopic Dermatitis Revenue Market Share by Country (2020-2031)
Figure 27. Germany Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Medications for Canine Atopic Dermatitis Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Medications for Canine Atopic Dermatitis Revenue Market Share by Region (2020-2031)
Figure 34. China Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Medications for Canine Atopic Dermatitis Sales Market Share by Country (2020-2031)
Figure 42. Latin America Medications for Canine Atopic Dermatitis Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Medications for Canine Atopic Dermatitis Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Medications for Canine Atopic Dermatitis Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Medications for Canine Atopic Dermatitis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Medications for Canine Atopic Dermatitis by Type (2020-2031)
Figure 52. Global Revenue Market Share of Medications for Canine Atopic Dermatitis by Type (2020-2031)
Figure 53. Global Medications for Canine Atopic Dermatitis Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Medications for Canine Atopic Dermatitis by Application (2020-2031)
Figure 55. Global Revenue Market Share of Medications for Canine Atopic Dermatitis by Application (2020-2031)
Figure 56. Global Medications for Canine Atopic Dermatitis Price (US$/Unit) by Application (2020-2031)
Figure 57. Medications for Canine Atopic Dermatitis Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
